Moreover, miR-214 also enhances the activity of the EGFR and TGF-β signaling pathways by targeting Mig6, a negative regulator of EGFR signaling, thereby promoting HSC activation and liver fibrosis 119. The gene discussed is TGFB1; the disease is Hepatic fibrosis.